Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 374

1.

Improved method for the catheterization of the right ventricle in a rat model of pulmonary artery hypertension.

Tontodonati M, Ridley D, Remie R, Clements P.

Interact Cardiovasc Thorac Surg. 2020 Jan 21. pii: ivz314. doi: 10.1093/icvts/ivz314. [Epub ahead of print]

PMID:
31965143
2.

Simultaneous measurement of contraction, voltage and calcium in HIPSC-CMS for the detection of inotropic effects under blinded conditions.

de Korte T, van Meer B, Garcia AK, Tertoolen L, Clements PJ, Bahinski A, Rossman EI, Xu X, Turner S, Denning C, Vlaming M, Braam S, Mummery C.

J Pharmacol Toxicol Methods. 2019 Sep - Oct;99:106595. doi: 10.1016/j.vascn.2019.05.170. Epub 2019 Oct 17. No abstract available.

PMID:
31962931
3.

The Quality Of Evidence In Preclinical Medical Education Literature: A Systematic Review.

Leif M, Semarad N, Ganesan V, Selting K, Burr J, Svec A, Clements P, Talmon G.

Adv Med Educ Pract. 2019 Nov 1;10:925-933. doi: 10.2147/AMEP.S212858. eCollection 2019.

4.

Unlocking Personalized Biomedicine and Drug Discovery with Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Fit for Purpose or Forever Elusive?

de Korte T, Katili PA, Mohd Yusof NAN, van Meer BJ, Saleem U, Burton FL, Smith GL, Clements P, Mummery CL, Eschenhagen T, Hansen A, Denning C.

Annu Rev Pharmacol Toxicol. 2020 Jan 6;60:529-551. doi: 10.1146/annurev-pharmtox-010919-023309. Epub 2019 Sep 10.

PMID:
31506008
5.

Progression of Interstitial Lung Disease in Systemic Sclerosis: The Importance of Pneumoproteins Krebs von den Lungen 6 and CCL18.

Volkmann ER, Tashkin DP, Kuwana M, Li N, Roth MD, Charles J, Hant FN, Bogatkevich GS, Akter T, Kim G, Goldin J, Khanna D, Clements PJ, Furst DE, Elashoff RM, Silver RM, Assassi S.

Arthritis Rheumatol. 2019 Dec;71(12):2059-2067. doi: 10.1002/art.41020. Epub 2019 Nov 1.

PMID:
31233287
6.

The Effects of Intimate Partner Violence on Children: Navigating Therapeutic Assessment and Intervention.

Clements PT, Fay-Hillier T.

Issues Ment Health Nurs. 2019 Jun;40(6):486-492. doi: 10.1080/01612840.2018.1553000. Epub 2019 Mar 27.

PMID:
30917053
7.

An Interim Report of the Scleroderma Clinical Trials Consortium Working Groups.

Baron M, Kahaleh B, Bernstein EJ, Chung L, Clements PJ, Denton C, Domsic RT, Ferdowsi N, Foeldvari I, Frech T, Gordon JK, Hudson M, Johnson SR, Khanna D, McMahan Z, Merkel PA, Narain S, Nikpour M, Pauling JD, Ross L, Valenzuela Vergara AM, Vacca A.

J Scleroderma Relat Disord. 2019 Feb;4(1):17-27. doi: 10.1177/2397198318783926. Epub 2018 Jul 18.

8.

Confronting Incivility in the Online Classroom.

Swartzwelder K, Clements P, Holt K, Childs G.

J Christ Nurs. 2019 Apr/Jun;36(2):104-111. doi: 10.1097/CNJ.0000000000000591.

PMID:
30865091
9.

Cyclophosphamide for Systemic Sclerosis-related Interstitial Lung Disease: A Comparison of Scleroderma Lung Study I and II.

Volkmann ER, Tashkin DP, Sim M, Li N, Khanna D, Roth MD, Clements PJ, Hoffmann-Vold AM, Furst DE, Kim G, Goldin J, Elashoff RM.

J Rheumatol. 2019 Oct;46(10):1316-1325. doi: 10.3899/jrheum.180441. Epub 2019 Feb 15.

PMID:
30770517
10.

Minimal Clinically Important Differences for the Modified Rodnan Skin Score: Results from the Scleroderma Lung Studies (SLS-I and SLS-II).

Khanna D, Clements PJ, Volkmann ER, Wilhalme H, Tseng CH, Furst DE, Roth MD, Distler O, Tashkin DP.

Arthritis Res Ther. 2019 Jan 16;21(1):23. doi: 10.1186/s13075-019-1809-y.

11.

Evolving the Role of Discovery-focused Pathologists and Comparative Scientists in the Pharmaceutical Industry.

Mohanan S, Maguire S, Klapwijk J, Adler R, Haworth R, Clements P.

Toxicol Pathol. 2019 Feb;47(2):121-128. doi: 10.1177/0192623318821333. Epub 2019 Jan 16.

PMID:
30651043
12.

Short-term progression of interstitial lung disease in systemic sclerosis predicts long-term survival in two independent clinical trial cohorts.

Volkmann ER, Tashkin DP, Sim M, Li N, Goldmuntz E, Keyes-Elstein L, Pinckney A, Furst DE, Clements PJ, Khanna D, Steen V, Schraufnagel DE, Arami S, Hsu V, Roth MD, Elashoff RM, Sullivan KM; SLS I and SLS II study groups.

Ann Rheum Dis. 2019 Jan;78(1):122-130. doi: 10.1136/annrheumdis-2018-213708. Epub 2018 Nov 8.

13.

Information-Derived Mechanistic Hypotheses for Structural Cardiotoxicity.

Svensson F, Zoufir A, Mahmoud S, Afzal AM, Smit I, Giblin KA, Clements PJ, Mettetal JT, Pointon A, Harvey JS, Greene N, Williams RV, Bender A.

Chem Res Toxicol. 2018 Nov 19;31(11):1119-1127. doi: 10.1021/acs.chemrestox.8b00159. Epub 2018 Oct 17.

PMID:
30350600
14.

Longitudinal Changes in Quantitative Interstitial Lung Disease on Computed Tomography after Immunosuppression in the Scleroderma Lung Study II.

Goldin JG, Kim GHJ, Tseng CH, Volkmann E, Furst D, Clements P, Brown M, Roth M, Khanna D, Tashkin DP.

Ann Am Thorac Soc. 2018 Nov;15(11):1286-1295. doi: 10.1513/AnnalsATS.201802-079OC.

15.

Intersection of Human Trafficking and the Emergency Department.

Lamb-Susca L, Clements PT.

J Emerg Nurs. 2018 Nov;44(6):563-569. doi: 10.1016/j.jen.2018.06.001. Epub 2018 Aug 24. Review.

PMID:
30149896
16.

An Interesting Case of Neurobrucellosis Mimicking Neuropsychiatric Lupus.

Bains R, Dahhan T, Belzowski A, Heinze ER, Wong AL, Clements PJ.

Case Rep Rheumatol. 2018 Jul 8;2018:9793535. doi: 10.1155/2018/9793535. eCollection 2018.

17.

Development of minimum standards of care for juvenile localized scleroderma.

Constantin T, Foeldvari I, Pain CE, Pálinkás A, Höger P, Moll M, Nemkova D, Weibel L, Laczkovszki M, Clements P, Torok KS.

Eur J Pediatr. 2018 Jul;177(7):961-977. doi: 10.1007/s00431-018-3144-8. Epub 2018 May 4. Review.

PMID:
29728839
18.

Scleroderma renal crisis and renal involvement in systemic sclerosis.

Woodworth TG, Suliman YA, Li W, Furst DE, Clements P.

Nat Rev Nephrol. 2018 Feb;14(2):137. doi: 10.1038/nrneph.2017.183. Epub 2018 Jan 2.

PMID:
29292373
19.

Reliability and minimal clinically important differences of forced vital capacity: Results from the Scleroderma Lung Studies (SLS-I and SLS-II).

Kafaja S, Clements PJ, Wilhalme H, Tseng CH, Furst DE, Kim GH, Goldin J, Volkmann ER, Roth MD, Tashkin DP, Khanna D.

Am J Respir Crit Care Med. 2018 Mar 1;197(5):644-652. doi: 10.1164/rccm.201709-1845OC. Epub 2017 Nov 3.

20.

Ocular tissue distribution and pharmacokinetic study of a small 13kDa domain antibody after intravitreal, subconjuctival and eye drop administration in rabbits.

Gough G, Szapacs M, Shah T, Clements P, Struble C, Wilson R.

Exp Eye Res. 2018 Feb;167:14-17. doi: 10.1016/j.exer.2017.10.021. Epub 2017 Oct 23.

PMID:
29074387
21.

β-Cyclodextrin- and adamantyl-substituted poly(acrylate) self-assembling aqueous networks designed for controlled complexation and release of small molecules.

Yan L, Pham DT, Clements P, Lincoln SF, Wang J, Guo X, Easton CJ.

Beilstein J Org Chem. 2017 Sep 7;13:1879-1892. doi: 10.3762/bjoc.13.183. eCollection 2017.

22.

Muscle involvement in systemic sclerosis: points to consider in clinical trials.

Walker UA, Clements PJ, Allanore Y, Distler O, Oddis CV, Khanna D, Furst DE.

Rheumatology (Oxford). 2017 Sep 1;56(suppl_5):v38-v44. doi: 10.1093/rheumatology/kex196. Review.

23.

Points to consider for designing trials in systemic sclerosis patients with arthritic involvement.

Clements P, Allanore Y, Furst DE, Khanna D.

Rheumatology (Oxford). 2017 Sep 1;56(suppl_5):v23-v26. doi: 10.1093/rheumatology/kex194. Review.

24.

Where is the optimum placement of an interscalene brachial plexus nerve block?

Wang H, Clements P.

Br J Hosp Med (Lond). 2017 Sep 2;78(9):538. doi: 10.12968/hmed.2017.78.9.538. No abstract available.

PMID:
28898145
25.

Systemic sclerosis is associated with specific alterations in gastrointestinal microbiota in two independent cohorts.

Volkmann ER, Hoffmann-Vold AM, Chang YL, Jacobs JP, Tillisch K, Mayer EA, Clements PJ, Hov JR, Kummen M, Midtvedt Ø, Lagishetty V, Chang L, Labus JS, Molberg Ø, Braun J.

BMJ Open Gastroenterol. 2017 Apr 1;4(1):e000134. doi: 10.1136/bmjgast-2017-000134. eCollection 2017.

26.

Efficacy of Mycophenolate Mofetil and Oral Cyclophosphamide on Skin Thickness: Post Hoc Analyses From Two Randomized Placebo-Controlled Trials.

Namas R, Tashkin DP, Furst DE, Wilhalme H, Tseng CH, Roth MD, Kafaja S, Volkmann E, Clements PJ, Khanna D; Participants in the Scleroderma Lung Study I and members of the Scleroderma Lung Study II Research Group.

Arthritis Care Res (Hoboken). 2018 Mar;70(3):439-444. doi: 10.1002/acr.23282. Epub 2018 Feb 9.

27.

Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis.

Khanna D, Furst DE, Clements PJ, Allanore Y, Baron M, Czirjak L, Distler O, Foeldvari I, Kuwana M, Matucci-Cerinic M, Mayes M, Medsger T Jr, Merkel PA, Pope JE, Seibold JR, Steen V, Stevens W, Denton CP.

J Scleroderma Relat Disord. 2017 Jan-Apr;2(1):11-18. doi: 10.5301/jsrd.5000231.

28.

Structural Validity of the Rheumatology Attitudes Index in Systemic Sclerosis: Analysis from the UCLA Scleroderma Quality of Life Study.

Gholizadeh S, Mills SD, Fox RS, Merz EL, Roesch SC, Clements PJ, Kafaja S, Furst DE, Khanna D, Malcarne VL.

J Rheumatol. 2017 Jun;44(6):795-798. doi: 10.3899/jrheum.161080. Epub 2017 Apr 15.

29.

Mycophenolate Mofetil Versus Placebo for Systemic Sclerosis-Related Interstitial Lung Disease: An Analysis of Scleroderma Lung Studies I and II.

Volkmann ER, Tashkin DP, Li N, Roth MD, Khanna D, Hoffmann-Vold AM, Kim G, Goldin J, Clements PJ, Furst DE, Elashoff RM.

Arthritis Rheumatol. 2017 Jul;69(7):1451-1460. doi: 10.1002/art.40114. Epub 2017 May 23.

30.

A Rare Case of Digital Ischemia and Gangrene in ANCA-Associated Vasculitis with Review of the Literature.

Lau RA, Bains R, Suraweera D, Ma J, Heinze ER, Wong AL, Clements PJ.

Case Rep Rheumatol. 2017;2017:2421760. doi: 10.1155/2017/2421760. Epub 2017 Feb 28.

31.

Changes in plasma CXCL4 levels are associated with improvements in lung function in patients receiving immunosuppressive therapy for systemic sclerosis-related interstitial lung disease.

Volkmann ER, Tashkin DP, Roth MD, Clements PJ, Khanna D, Furst DE, Mayes M, Charles J, Tseng CH, Elashoff RM, Assassi S.

Arthritis Res Ther. 2016 Dec 30;18(1):305. doi: 10.1186/s13075-016-1203-y.

32.

Improved Cough and Cough-Specific Quality of Life in Patients Treated for Scleroderma-Related Interstitial Lung Disease: Results of Scleroderma Lung Study II.

Tashkin DP, Volkmann ER, Tseng CH, Roth MD, Khanna D, Furst DE, Clements PJ, Theodore A, Kafaja S, Kim GH, Goldin J, Ariolla E, Elashoff RM.

Chest. 2017 Apr;151(4):813-820. doi: 10.1016/j.chest.2016.11.052. Epub 2016 Dec 22.

33.

Update of EULAR recommendations for the treatment of systemic sclerosis.

Kowal-Bielecka O, Fransen J, Avouac J, Becker M, Kulak A, Allanore Y, Distler O, Clements P, Cutolo M, Czirjak L, Damjanov N, Del Galdo F, Denton CP, Distler JHW, Foeldvari I, Figelstone K, Frerix M, Furst DE, Guiducci S, Hunzelmann N, Khanna D, Matucci-Cerinic M, Herrick AL, van den Hoogen F, van Laar JM, Riemekasten G, Silver R, Smith V, Sulli A, Tarner I, Tyndall A, Welling J, Wigley F, Valentini G, Walker UA, Zulian F, Müller-Ladner U; EUSTAR Coauthors.

Ann Rheum Dis. 2017 Aug;76(8):1327-1339. doi: 10.1136/annrheumdis-2016-209909. Epub 2016 Nov 9.

34.

Scleroderma renal crisis and renal involvement in systemic sclerosis.

Woodworth TG, Suliman YA, Li W, Furst DE, Clements P.

Nat Rev Nephrol. 2016 Nov;12(11):678-691. doi: 10.1038/nrneph.2016.124. Epub 2016 Sep 19. Review. Erratum in: Nat Rev Nephrol. 2018 Jan 02;:.

PMID:
27641135
35.

Non-proliferative and Proliferative Lesions of the Cardiovascular System of the Rat and Mouse.

Berridge BR, Mowat V, Nagai H, Nyska A, Okazaki Y, Clements PJ, Rinke M, Snyder PW, Boyle MC, Wells MY.

J Toxicol Pathol. 2016;29(3 Suppl):1S-47S. doi: 10.1293/tox.29.3S-1. Epub 2016 Jul 29. Review.

36.

Management of Musculoskeletal Involvement in Systemic Sclerosis.

Clements P.

Curr Treatm Opt Rheumatol. 2016 Mar;2(1):61-68. Epub 2016 Feb 2. No abstract available.

37.

Health State Utilities and Disease Duration in Systemic Sclerosis: Is There an Association?

Raymakers AJ, Tsao NW, Marra CA, Clements PJ, Khanna D.

J Rheumatol. 2016 Oct;43(10):1832-1837. Epub 2016 Aug 1.

38.

Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial.

Tashkin DP, Roth MD, Clements PJ, Furst DE, Khanna D, Kleerup EC, Goldin J, Arriola E, Volkmann ER, Kafaja S, Silver R, Steen V, Strange C, Wise R, Wigley F, Mayes M, Riley DJ, Hussain S, Assassi S, Hsu VM, Patel B, Phillips K, Martinez F, Golden J, Connolly MK, Varga J, Dematte J, Hinchcliff ME, Fischer A, Swigris J, Meehan R, Theodore A, Simms R, Volkov S, Schraufnagel DE, Scholand MB, Frech T, Molitor JA, Highland K, Read CA, Fritzler MJ, Kim GHJ, Tseng CH, Elashoff RM; Sclerodema Lung Study II Investigators.

Lancet Respir Med. 2016 Sep;4(9):708-719. doi: 10.1016/S2213-2600(16)30152-7. Epub 2016 Jul 25.

39.

Management of Widespread Skin Thickening in Diffuse Systemic Sclerosis.

Kafaja S, Clements P.

Curr Treatm Opt Rheumatol. 2016 Mar;2(1):49-60. Epub 2016 Mar 11.

40.

Fever, Myositis, and Paralysis: Is This Inflammatory Myopathy or Neuroinvasive Disease?

Kiran AR, Lau RA, Wu KM, Wong AL, Clements PJ, Heinze ER.

Case Rep Rheumatol. 2016;2016:5395249. doi: 10.1155/2016/5395249. Epub 2016 Mar 28.

41.

Lung Transplant Outcomes in Systemic Sclerosis with Significant Esophageal Dysfunction. A Comprehensive Single-Center Experience.

Miele CH, Schwab K, Saggar R, Duffy E, Elashoff D, Tseng CH, Weigt S, Charan D, Abtin F, Johannes J, Derhovanessian A, Conklin J, Ghassemi K, Khanna D, Siddiqui O, Ardehali A, Hunter C, Kwon M, Biniwale R, Lo M, Volkmann E, Torres Barba D, Belperio JA, Sayah D, Mahrer T, Furst DE, Kafaja S, Clements P, Shino M, Gregson A, Kubak B, Lynch JP 3rd, Ross D, Saggar R.

Ann Am Thorac Soc. 2016 Jun;13(6):793-802. doi: 10.1513/AnnalsATS.201512-806OC.

42.

The American College of Rheumatology Provisional Composite Response Index for Clinical Trials in Early Diffuse Cutaneous Systemic Sclerosis.

Khanna D, Berrocal VJ, Giannini EH, Seibold JR, Merkel PA, Mayes MD, Baron M, Clements PJ, Steen V, Assassi S, Schiopu E, Phillips K, Simms RW, Allanore Y, Denton CP, Distler O, Johnson SR, Matucci-Cerinic M, Pope JE, Proudman SM, Siegel J, Wong WK, Wells AU, Furst DE.

Arthritis Rheumatol. 2016 Feb;68(2):299-311. doi: 10.1002/art.39501.

43.

The American College of Rheumatology Provisional Composite Response Index for Clinical Trials in Early Diffuse Cutaneous Systemic Sclerosis.

Khanna D, Berrocal VJ, Giannini EH, Seibold JR, Merkel PA, Mayes MD, Baron M, Clements PJ, Steen V, Assassi S, Schiopu E, Phillips K, Simms RW, Allanore Y, Denton CP, Distler O, Johnson SR, Matucci-Cerinic M, Pope JE, Proudman SM, Siegel J, Wong WK, Wells AU, Furst DE.

Arthritis Care Res (Hoboken). 2016 Feb;68(2):167-78. doi: 10.1002/acr.22804.

44.

Association of Systemic Sclerosis With a Unique Colonic Microbial Consortium.

Volkmann ER, Chang YL, Barroso N, Furst DE, Clements PJ, Gorn AH, Roth BE, Conklin JL, Getzug T, Borneman J, McGovern DP, Tong M, Jacobs JP, Braun J.

Arthritis Rheumatol. 2016 Jun;68(6):1483-92. doi: 10.1002/art.39572.

45.

Predictors of lung function decline in scleroderma-related interstitial lung disease based on high-resolution computed tomography: implications for cohort enrichment in systemic sclerosis-associated interstitial lung disease trials.

Khanna D, Nagaraja V, Tseng CH, Abtin F, Suh R, Kim G, Wells A, Furst DE, Clements PJ, Roth MD, Tashkin DP, Goldin J.

Arthritis Res Ther. 2015 Dec 23;17:372. doi: 10.1186/s13075-015-0872-2.

46.

Robust measurement of vitamin A status in plasma and blood dried on paper.

Huang Y, Clements PR, Gibson RA.

Prostaglandins Leukot Essent Fatty Acids. 2015 Dec;102-103:31-6. doi: 10.1016/j.plefa.2015.10.001. Epub 2015 Oct 13.

PMID:
26489594
47.

Evaluation of the Satisfaction with Appearance Scale and Its Short Form in Systemic Sclerosis: Analysis from the UCLA Scleroderma Quality of Life Study.

Mills SD, Fox RS, Merz EL, Clements PJ, Kafaja S, Malcarne VL, Furst DE, Khanna D.

J Rheumatol. 2015 Sep;42(9):1624-30. doi: 10.3899/jrheum.141482. Epub 2015 Jun 1.

48.

Development of a Composite Outcome Measure for Systemic Sclerosis Related Interstitial Lung Disease.

Volkmann ER, Tashkin DP, Li N, Furst DE, Clements PJ, Elashoff RM.

Rheumatology (Sunnyvale). 2015 Jun;5(2). pii: 154. doi: 10.4172/2161-1149.1000154. Epub 2015 Jun 30.

49.

Relationship between quantitative radiographic assessments of interstitial lung disease and physiological and clinical features of systemic sclerosis.

Tashkin DP, Volkmann ER, Tseng CH, Kim HJ, Goldin J, Clements P, Furst D, Khanna D, Kleerup E, Roth MD, Elashoff R.

Ann Rheum Dis. 2016 Feb;75(2):374-81. doi: 10.1136/annrheumdis-2014-206076. Epub 2014 Dec 1.

PMID:
25452309
50.

Acute hemorrhagic myositis in inflammatory myopathy and review of the literature.

Van Gelder H, Wu KM, Gharibian N, Patel DB, Clements PJ, Heinze ER, Morris RI, Wong AL.

Case Rep Rheumatol. 2014;2014:639756. doi: 10.1155/2014/639756. Epub 2014 Oct 14.

Supplemental Content

Loading ...
Support Center